comment: use of biosimilar monoclonal antibodies in the clinic
Published 4 years ago • 60 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
4:40
practical guidance on the assessment of biosimilar monoclonal antibodies: a physician's perspective
-
3:17
practical guidance on the assessment of biosimilar monoclonal antibodies: a pharmacist's perspec...
-
1:28
comment: immunogenicity of biosimilars
-
1:28
the role of pharmacists when introducing biosimilar monoclonal antibodies into practice
-
5:29
the science of biosimilarity: immunogenicity
-
3:48
what is the use for monoclonal antibodies in mpn?
-
2:40
elcc 2010: the use of monoclonal antibodies to treat mesothelioma
-
2:14
melarisk-001: validation of a 7-marker ihc assay in stage ib/iia cutaneous melanoma
-
1:41
what are monoclonal antibodies?
-
1:26
emerging monoclonal antibodies for the treatment of multiple myeloma
-
3:20
how monoclonal antibodies treat cancer
-
38:15
biosimilars and biologics
-
1:54
biosimilars are alternatives for original antibodies
-
17:59
what is the potential for using monoclonal antibodies in multiple myeloma?
-
11:49
how do monoclonal antibodies work? rituximab, infliximab, adalimumab and others
-
20:57
mcrt phoenix 2017: monoclonal antibodies and immunotherapies by leif bergsagel, md
-
3:32
monoclonal antibodies and its production
-
34:13
which is the most important target for monoclonal antibodies in myeloma therapy?
-
4:55
clinical potential of trastuzumab biosimilar ctp6